英文字典,中文字典,查询,解释,review.php


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       


安装中文字典英文字典辞典工具!

安装中文字典英文字典辞典工具!










  • KDIGO 2024 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF . . .
    KDIGO 2024 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF IMMUNOGLOBULIN A NEPHROPATHY (IgAN) AND IMMUNOGLOBULIN A VASCULITIS (IgAV) PUBLIC REVIEW DRAFT AUGUST 2024 Patients with IgA nephropathy: Targeted-release budesonide (nefecon) for 9 months vs
  • IgA Nephropathy (IgAN) IgA Vasculitis (IgAV) - KDIGO
    The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) was recently available for public review The guideline is now being prepared for publication, incorporating feedback received during the public review period You can view the KDIGO IgAN IgAV Guideline Public Review Draft Summary of Recommendations and Practice Points below
  • KDIGO 2024 IgAN IgAN Guideline Draft Available for Public Review
    KDIGO is updating The 2021 Clinical Practice Guideline for the Management of Glomerular Diseases on an ongoing, chapter-by-chapter basis The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) is available for public review through Monday, September 30 The update takes into consideration evidence from randomized controlled trials
  • Glomerular Diseases (GD) – KDIGO
    KDIGO is updating The 2021 Clinical Practice Guideline for the Management of Glomerular Diseases on an ongoing, chapter-by-chapter basis The KDIGO 2025 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) is being revised based on feedback received during the public review period The guideline is expected to be published in the fall of 2025
  • Guidelines – KDIGO
    The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) was recently available for public review The guideline is now being prepared for publication, incorporating feedback received during the public review period August 21, 2024
  • How I Treat IgA Nephropathy - KDIGO
    Global Outcomes (KDIGO) 2021 guidelines recommend a systolic target in most adult patients with IgA nephropathy of ,120 mm Hg measured in a standard-ized fashion (3) (Figure 1) IgA nephropathy; although reduction in triglycerides has been described, use of fish oil is also not associated with reduction in cardiovascular events (7)
  • Updates in IgA Nephropathy – KDIGO
    Dr Rovin and Dr Floege are currently co-chairing the forthcoming KDIGO 2025 IgA Nephropathy IgA Vasculitis and Nephrotic Syndrome in Children Guidelines They have also co-chaired the 2024 Lupus Nephritis and ANCA Vasculitis Guidelines and the 2021 Glomerular Diseases Guideline These videos, recorded in October 2024 in San Diego, California
  • The KDIGO 2024 Clinical Practice Guideline for the Management of IgA . . .
    The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) is available for public review through Monday, September 30


















中文字典-英文字典  2005-2009